跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 44 条关于
“CHIKV”
全部
44
临床试验
14
药物
18
机构
0
资讯
12
去年
Valneva's Chikungunya Vaccine Shows Two-Year Antibody Persistence in Adults
去年
Valneva's Chikungunya Vaccine Shows Sustained Antibody Response in Children After Six Months
去年
European Commission Approves First Chikungunya Vaccine from Bavarian Nordic
去年
FDA Gears Up for Key Decisions on Vaccines and Novel Therapies in H1 2025
去年
Valneva Expands Chikungunya Vaccine Access in Asia Through Collaboration with Serum Institute of India
去年
FDA Approves Valneva's Ixchiq: First Chikungunya Vaccine
2年前
Valneva Seeks to Expand IXCHIQ Chikungunya Vaccine Label to Adolescents in Europe and Canada
去年
Valneva's IXCHIQ Shows Sustained Immune Response in Adolescents and Positive Phase 2 Results in Children
去年
EMA Suspends Valneva's IXCHIQ Chikungunya Vaccine for Elderly Following Safety Concerns
去年
Valneva Seeks FDA Approval to Extend IXCHIQ Chikungunya Vaccine to Adolescents
第 1 页,共 2 页
上一页
下一页